معرفی
Professor Richard Haynes is a Professor of Renal Medicine and Clinical Trials at the University of Oxford, affiliated with the Clinical Trial Service Unit & Epidemiological Studies Unit and the Medical Sciences Division. As an honorary consultant nephrologist at the Oxford Kidney Unit, he co-leads the Renal Studies Group and spearheads global health science initiatives through teaching roles in the MSc programs.
- Co-director of Clinical Trial Service Unit & Epidemiological Studies Unit
- Module 8 lead: Clinical Trials and Meta-analysis
His research spans clinical trials methodology, nephrology, and epidemiology, with notable work on:
- Renal transplantation (3C Study)
- Chronic kidney disease (EMPA-KIDNEY)
- Cardiovascular trials (RECOVERY, UK HARP-III)
- Outbreak response (PLATINUM for mpox, PARTNERS for filovirus)
Recent publications highlight his contributions to SARS-CoV-2 treatment strategies and SGLT2 inhibitor applications in renal care. He advocates for integrating randomization into clinical practice globally.
Scientific Awards
- MBE in the 2021 New Year Honours
He actively engages in teaching and trial design innovation, with a focus on streamlining research protocols for outbreak scenarios and routine healthcare implementation.
